Retatrutide

Triple Receptor. One Compound.

A next-generation peptide studied for its unique ability to engage three metabolic receptors at once — GIP, GLP-1, and glucagon. Researchers are exploring how this triple-agonist mechanism influences energy regulation, glucose signaling, and metabolic efficiency — positioning it as one of the most advanced compounds currently under investigation in metabolic research.

Key Research Areas

•Triple GIP, GLP-1, and glucagon receptor pathway research

•Advanced glucose regulation and insulin signaling modulation

•Energy expenditure and metabolic efficiency pathway research

Third-party tested for purity and endotoxins.
Strictly for laboratory research and analytical purposes. Not for human consumption.